Literature DB >> 26303259

[Percutaneous needle aponeurotomy for Dupuytren's disease].

C K Spies1, L P Müller2, E Skouras2, D Bassemir3, P Hahn3, F Unglaub3,4.   

Abstract

OBJECTIVE: Percutaneous transverse aponeurotomy of the cord by using a hypodermic needle as a scalpel blade in order to improve function of the hand. INDICATIONS: Symptomatic flexion contracture with positive table top test caused by a single, palpable cord within the palm (primarily Tubiana stages I and II). CONTRAINDICATIONS: Multiple, infiltrating or broad-based cords within the palm; irritated skin conditions; exclusive digital cord localization; recurrence after aponeurectomy; previous surgical intervention at the site of interest, digital nerve lesions; lack of patient compliance. SURGICAL TECHNIQUE: Pinpoint surface anesthesia is obtained by injecting each portal area subdermally with 0.1 ml of local anesthetic. These applications start from distally to proximally within the palm while the most distal injection site is located proximal to the distal palm crease. Then the needle tip is introduced perpendicular to the cord. Sawing movements through the cord are performed transversely. While passively extending the contracted finger, the cord is held under tension which guarantees safe cutting. Patients are encouraged to report immediate pain sensation or numbness in order to prevent injuries to neurovascular structures and active finger flexion excludes tendon lesions during the procedure. Introducing the needle tip may be performed at several sites along the cord, if necessary, from distal to proximal at least 5 mm apart with prior pinpoint surface anesthesia. Finally, cautious passive stretching may be done after each release. POSTOPERATIVE MANAGEMENT: Bandaging allowing immediate motion; application of a hand-based extension splint-glove during the night for 3-6 months.
RESULTS: Recurrence rate was 53% in 15 retrospectively examined patients after a mean interval of 40 months postoperatively.

Entities:  

Keywords:  Aponeurotomy; Contracture; Dupuytren’s disease; Fasziotomy; Percutaneous needle aponeurotomy

Mesh:

Year:  2015        PMID: 26303259     DOI: 10.1007/s00064-015-0417-5

Source DB:  PubMed          Journal:  Oper Orthop Traumatol        ISSN: 0934-6694            Impact factor:   1.154


  14 in total

1.  Treatment of stages IIIIV of the Dupuytrens Disease using a personal approach: percutaneous needle fasciotomy (PNF) and minimal invasive selective aponeurectomy.

Authors:  B Corradino; S Di Lorenzo; F Moschella
Journal:  Acta Chir Plast       Date:  2013

2.  Five-year results of a randomized clinical trial on treatment in Dupuytren's disease: percutaneous needle fasciotomy versus limited fasciectomy.

Authors:  Annet L van Rijssen; Hein Ter Linden; Paul M N Werker
Journal:  Plast Reconstr Surg       Date:  2012-02       Impact factor: 4.730

3.  Results of needle aponeurotomy for Dupuytren contracture in over 1,000 fingers.

Authors:  Gary M Pess; Rebecca M Pess; Rachel A Pess
Journal:  J Hand Surg Am       Date:  2012-04       Impact factor: 2.230

4.  Percutaneous needle fasciotomy in dupuytren's disease.

Authors:  A L van Rijssen; P M N Werker
Journal:  J Hand Surg Br       Date:  2006-06-12

5.  Dupuytren's contracture: an analysis of outcomes of percutaneous needle fasciotomy versus open fasciectomy.

Authors:  Jason T Toppi; Leisel Trompf; Nicolas R Smoll; Vivian Lim; Katrina Smith; Michael W Findlay; David J Hunter-Smith
Journal:  ANZ J Surg       Date:  2014-01-20       Impact factor: 1.872

6.  Posterior interosseus nerve vs. medial cutaneous nerve of the forearm: differences in digital nerve reconstruction.

Authors:  F Stang; P Stollwerck; K J Prommersberger; J van Schoonhoven
Journal:  Arch Orthop Trauma Surg       Date:  2013-03-28       Impact factor: 3.067

7.  Percutaneous fasciotomy for the treatment of Dupuytren's disease-a systematic review.

Authors:  Saoussen Salhi; Etienne Cardin-Langlois; Mario Luc
Journal:  Hand (N Y)       Date:  2011-08-19

8.  Ultrasonographic evaluation of displaced neurovascular bundle in Dupuytren disease.

Authors:  Kosuke Uehara; Toshiki Miura; Yutaka Morizaki; Hideaki Miyamoto; Takashi Ohe; Sakae Tanaka
Journal:  J Hand Surg Am       Date:  2012-12-04       Impact factor: 2.230

9.  [Dupuytren's disease - patient satisfaction and functional results one year after partial fasciectomy and injection of collagenase].

Authors:  F H Vollbach; L Walle; H Fansa
Journal:  Handchir Mikrochir Plast Chir       Date:  2013-10-02       Impact factor: 1.018

10.  The Re-Emergence of Percutaneous Fasciotomy in the Management of Dupuytren's Disease.

Authors:  James Donaldson; Nicholas Goddard
Journal:  Open Orthop J       Date:  2012-02-23
View more
  3 in total

Review 1.  [Percutaneous needle aponeurotomy for Dupuytren's contracture].

Authors:  J Oppermann; F Unglaub; L P Müller; S Löw; P Hahn; C K Spies
Journal:  Orthopade       Date:  2017-04       Impact factor: 1.087

2.  [Treatment of Dupuytren's disease with collagenase Clostridium histolyticum].

Authors:  M Keller; R Arora; G Schmiedle; T Kastenberger
Journal:  Orthopade       Date:  2017-04       Impact factor: 1.087

Review 3.  [The fibrous skeleton of the hand : Changes with Dupuytren's contracture].

Authors:  M F Langer; J Grünert; F Unglaub; B Wieskötter; S Oeckenpöhler
Journal:  Orthopade       Date:  2017-04       Impact factor: 1.087

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.